Logo image of LTRPA

LIBERTY TRIPADVISOR HDG-A (LTRPA) Stock Fundamental Analysis

NASDAQ:LTRPA - Nasdaq - US5314651028 - Common Stock - Currency: USD

0.26  -0.07 (-20.83%)

After market: 0.25 -0.01 (-3.85%)

Fundamental Rating

2

LTRPA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 70 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of LTRPA have multiple concerns. LTRPA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

LTRPA had negative earnings in the past year.
In the past year LTRPA had a positive cash flow from operations.
In the past 5 years LTRPA reported 4 times negative net income.
Of the past 5 years LTRPA 4 years had a positive operating cash flow.
LTRPA Yearly Net Income VS EBIT VS OCF VS FCFLTRPA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.65%, LTRPA is in the better half of the industry, outperforming 64.18% of the companies in the same industry.
LTRPA has a Return On Invested Capital of 1.52%. This is in the better half of the industry: LTRPA outperforms 67.16% of its industry peers.
Industry RankSector Rank
ROA -0.65%
ROE N/A
ROIC 1.52%
ROA(3y)-4.4%
ROA(5y)-2.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LTRPA Yearly ROA, ROE, ROICLTRPA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50

1.3 Margins

Looking at the Operating Margin, with a value of 4.53%, LTRPA is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
LTRPA's Operating Margin has improved in the last couple of years.
LTRPA does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 4.53%
PM (TTM) N/A
GM N/A
OM growth 3Y-10.65%
OM growth 5Y72.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LTRPA Yearly Profit, Operating, Gross MarginsLTRPA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40 -60

3

2. Health

2.1 Basic Checks

LTRPA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LTRPA has been increased compared to 1 year ago.
Compared to 1 year ago, LTRPA has an improved debt to assets ratio.
LTRPA Yearly Shares OutstandingLTRPA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
LTRPA Yearly Total Debt VS Total AssetsLTRPA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B

2.2 Solvency

LTRPA has an Altman-Z score of 0.43. This is a bad value and indicates that LTRPA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.43, LTRPA is not doing good in the industry: 64.18% of the companies in the same industry are doing better.
LTRPA has a debt to FCF ratio of 6.02. This is a slightly negative value and a sign of low solvency as LTRPA would need 6.02 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.02, LTRPA is in the better half of the industry, outperforming 67.16% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.02
Altman-Z 0.43
ROIC/WACC0.52
WACC2.92%
LTRPA Yearly LT Debt VS Equity VS FCFLTRPA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M 1B

2.3 Liquidity

LTRPA has a Current Ratio of 1.77. This is a normal value and indicates that LTRPA is financially healthy and should not expect problems in meeting its short term obligations.
LTRPA has a Current ratio (1.77) which is comparable to the rest of the industry.
LTRPA has a Quick Ratio of 1.77. This is a normal value and indicates that LTRPA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of LTRPA (1.77) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
LTRPA Yearly Current Assets VS Current LiabilitesLTRPA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The earnings per share for LTRPA have decreased strongly by -120.36% in the last year.
The Revenue has grown by 37.20% in the past year. This is a very strong growth!
The Revenue has been decreasing by -1.00% on average over the past years.
EPS 1Y (TTM)-120.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.27%
Revenue 1Y (TTM)37.2%
Revenue growth 3Y-1.47%
Revenue growth 5Y-1%
Sales Q2Q%18.47%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
LTRPA Yearly Revenue VS EstimatesLTRPA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B
LTRPA Yearly EPS VS EstimatesLTRPA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 0.5 -0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LTRPA. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LTRPA Price Earnings VS Forward Price EarningsLTRPA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, LTRPA is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.1
EV/EBITDA -0.01
LTRPA Per share dataLTRPA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LTRPA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIBERTY TRIPADVISOR HDG-A

NASDAQ:LTRPA (10/27/2023, 8:28:06 PM)

After market: 0.25 -0.01 (-3.85%)

0.26

-0.07 (-20.83%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-03 2023-11-03/amc
Earnings (Next)02-15 2024-02-15/bmo
Inst Owners0.03%
Inst Owner Change-99.56%
Ins Owners12.5%
Ins Owner Change-123.63%
Market Cap19.91M
Analysts40
Price Target5.1 (1861.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.1
P/OCF 0.08
P/B N/A
P/tB N/A
EV/EBITDA -0.01
EPS(TTM)-0.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)2.49
FCFY959.53%
OCF(TTM)3.28
OCFY1260.95%
SpS21.92
BVpS-1.95
TBVpS-41.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.65%
ROE N/A
ROCE 1.93%
ROIC 1.52%
ROICexc 2.17%
ROICexgc N/A
OM 4.53%
PM (TTM) N/A
GM N/A
FCFM 11.38%
ROA(3y)-4.4%
ROA(5y)-2.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y104.93%
ROICexcg growth 5Y216.84%
ROICexc growth 3Y-4.07%
ROICexc growth 5Y83.96%
OM growth 3Y-10.65%
OM growth 5Y72.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 6.02
Debt/EBITDA 6.96
Cap/Depr 67.42%
Cap/Sales 3.58%
Interest Coverage 250
Cash Conversion 152.12%
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 0.43
F-Score4
WACC2.92%
ROIC/WACC0.52
Cap/Depr(3y)42.16%
Cap/Depr(5y)42.74%
Cap/Sales(3y)6.28%
Cap/Sales(5y)5.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-120.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-85.27%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)37.2%
Revenue growth 3Y-1.47%
Revenue growth 5Y-1%
Sales Q2Q%18.47%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y7700%
EBIT growth 3Y-11.97%
EBIT growth 5Y71.11%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3720%
FCF growth 3Y2.74%
FCF growth 5Y16.75%
OCF growth 1Y412.25%
OCF growth 3Y-0.09%
OCF growth 5Y12.23%